Subcellular remodeling and heart dysfunction in cardiac hypertrophy due to pressure overload

Annals of the New York Academy of Sciences

Volumn 874, Issue , 1999, Pages 100-110

  Dhalla, Naranjan S ^a,b   Golfman, Leonard ^a,b   Liu, Xueliang ^a,b   Sasaki, Hideki ^a,b   Elimban, Vijayan ^a,b   Rupp, Heinz ^a,b  

^a ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM ION; ETOMOXIR; MESSENGER RNA; MYOSIN HEAVY CHAIN;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CALCIUM TRANSPORT; CONFERENCE PAPER; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME ACTIVITY; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE OVERLOAD; HEART MUSCLE METABOLISM; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; MUSCLE FIBRIL; NONHUMAN; PROTEIN CONTENT; RAT; RNA ANALYSIS; SARCOPLASMIC RETICULUM;

EID: 0032789234     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb09228.x     Document Type: Conference Paper

References (30)

1. 1. HAMRELL, B.B. & N.R. ALPERT. 1997. The mechanical characteristics of hypertrophied rabbit cardiac muscle in the absence of congestive heart failure. Circ. Res. 40: 20-25.
2. 2. WIKMAN-COFFELT, J., W.W. PARMLEY & D.T. MASON. 1979. The cardiac hypertrophy process. Analyses of factors determining pathological vs. physiological development. Circ. Res. 45: 697-707.
3. 3. JULIAN, F.J., D.L. MORGAN, R.L. MOSS, M. GONZALEZ & P. DWIVEDI. 1981. Myocyte growth without physiological impairment in gradually induced cardiac hypertrophy. Circ. Res. 49: 1300-1310.
4. 4. SCHEUER, J., A. MALHOTRA, C. HIRSCH, J. CAPASSO & T.F. SHAIBLE. 1982. Physiologic cardiac hypertrophy corrects contractile protein abnormalities associated with pathologic hypertrophy. J. Clin. Invest. 70: 1300-1305.
5. 5. DHALLA, N.S., C.E. HEYLIGER, R.E. BEAMISH & I.R. INNES. 1987. Pathophysiological aspect of myocardial hypertrophy. Can. J. Cardiol. 3: 183-196.
6. 6. GANGULY, P.K., S.-L. LEE, R.E. BEAMISH & N.S. DHALLA. 1989. Altered sympathetic system and adrenoceptors during the development of cardiac hypertrophy. Am. Heart J. 118: 520-525.
7. 7. BAKER, K.M., M.I. CHERMIN, S.K. WIXSON & J.F. ACETO. 1990. Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. Am. J. Physiol. 259: H324-H332.
8. 8. RUPP, H., V. ELIMBAN & N.S. DHALLA. 1992. Modification of subcellular organelles in pressure-overloaded heart by etomoxir, a carnitine palmitoyltransferase 1 inhibitor. FASEB J. 6: 2349-2353.
9. 9. ZARAIN-HERZBERG, A., H. RUPP, V. ELIMBAN & N.S. DHALLA. 1996. Modification of sarcoplasmic reticulum gene expression in pressure overload cardiac hypertrophy by etomoxir. FASEB J. 10: 1303-1309.
10. 10. SCHAUB, M.C., M.A. HEFTI, R.A. ZUELLIG & I. MARANO. 1997. Modulation of contractility in human cardiac hypertrophy by rnyosin essential light chain isoforms. Cardiovasc, Res. 37: 381-404.
11. 11. MERCADIER, J.J., A.M. LOMPRE, C. WISNEWSKY, J.L. SAMUEL, J. BERCOVICI, B. SWYNGHEDAUW & K. SCHWARTZ. 1981. Myosin isoenzyme changes in several models of rat cardiac hypertrophy. Circ. Res. 49: 525-532.
12. 12. ALPERT, N. & L.A. MULIERI. 1982. Heart mechanics and rnyosin ATPase in normal and hypertrophied heart muscle. Fed. Proc. 41: 192-198.
13. 13. RUPP, H. 1981. The adaptive changes in the isoenzyme pattern of rnyosin from hypertrophied rat myocardium as a result of pressure overload and physical training. Basic Res. Cardiol. 76: 79-88.
14. 14. SIEMANKOWSKI, R.F. & P. OREIZEN. 1978. Canìne cardiac rnyosin with special reference to pressure overload cardiac hypertrophy. J. Biol. Chem. 253: 8659-8665.
15. 15. LITTEN, R.Z., J.E. BRAYDEN & N.R. ALPERT. 1978. The ATPase activity of subfragment-1 from the hypertrophied heart. Biochim. Biophys. Acta 523: 377-384.
16. 16. HEYLIGER, C.E., P.K. GANGULY & N.S. DHALLA. 1985. Sarcoplasmic reticular and mitochondrial calcium transport in cardiac hypertrophy. Can. J. Cardiol. 1: 401-408.
17. 17. ITO, Y., J. SUKO & C.A. CHIDSEY. 1974. Intracellular calcium and myocardial contractility. V. Calcium uptake of sarcoptasmic reticulum functions in hypertrophied and failing rabbit hearts. J. Mol. Cell. Cardiol. 6: 237-247.
18. 18. LAMERS, J.M.J. & J.T. STIMIS. 1979. Defective calcium pump in the sarcoplasmic reticulum of the hypertrophied rabbit. Life Sci. 24: 2313-2320.
19. 19. LIMAS, C.J., S.S. SPIER & J. KAHLON. 1980. Enhanced calcium transport by sarcoplasmic reticulum in mild cardiac hypertrophy. J. Mol. Cell. Cardiol. 12: 1103-1116.
20. 20. SORDAHL, L.A., W.B. MCCULLUM, W.G. WOOD & A. SCHWARTZ. 1973. Mitochondria and sarcoplasmic reticulum functions in cardiac hypertrophy and failure. Am. J. Physiol. 224: 497-502.
21. 21. DHALLA, N.S., C. HEYLIGER, K.R. SHAH, R. SETHI, N. TAKEDA & M. NAGANO. 1994. Remodeling of membrane systems during the development of cardiac hypertrophy due to pressure overload. In The Adapted Heart. M. Nagano, N. Takeda & N.S. Dhalla, Eds.: 27-49. Raven Press. New York, NY.
22. 22. DIXON, I.M.C., S.-L. LEE & N.S. DHALLA. 1990. Nitrendipine binding in congestive heart failure due to myocardial infarction. Circ. Res. 66: 782-788.
23. 23. PIERCE, G.N. & N.S. DHALLA. 1985. Mechanisms of the defect in cardiac myofibrillar function during diabetes. Am. J. Physiol. 248: E170-E175.
24. 24. GANGULY, P.K., G.N. PIERCE & N.S. DHALLA. 1983. Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy. Am. J. Physiol. 244: E528-E535.
25. 25. OSADA, M., T. NETTICADAN, K. TAMURA & N.S. DHALLA. 1998. Modification of ischemia-reperfusion-induced changes in cardiac sarcoplasmic reticulum by preconditioning. Am. J. Physiol. 274: H2025-H2034.
26. 26. CHOMCZYNSKI, P. & N. SACCHI. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159.
27. 27. SAMBROOK, J., E.F. FRITSCH & T. MANIATIS. 1989. Molecular Cloning: A Laboratory Manual. 2nd edit. Cold Spring Harbor Laboratory. Cold Spring Harbor, NY.
28. 28. VETTER, R., M. KOTT & H. RUPP. 1995. Differential influences of carnitine palmitoyltransferase-1 inhibition and hyperthyroidism on cardiac growth and sarcoplasmic reticulum phosphorylation. Eur. Heart J. 16: 15-19.
29. 29. VETTER, R. & H. RUPP. 1994. CPT-1 inhibition by etomoxir has a chamber-related action on cardiac sarcoplasmic reticulum and isoenzymes. Am. J. Physiol. 267: H2091-H2099.
30. 30. RUPP, H., R. WAHL & M. HANSEN. 1992. Influence of diet and carnitine palmitoyltransferase-1 inhibition on myosin and sarcoplasmic reticulum. J. Appl. Physiol. 72: 352-360.